Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lafyatis

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Targeting fibrosis in systemic sclerosisRobert Lafyatis
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2016
Editorial: Epigenetics in Systemic SclerosisRobert Lafyatis
Nature Reviews. Rheumatology|July 4, 2012
Connective tissue disease: SSc-fibrosis takes flight with Wingless inhibitionRobert Lafyatis
Current Rheumatology Reports|November 5, 2011
Application of biomarkers to clinical trials in systemic sclerosisRobert Lafyatis
Nature Reviews. Rheumatology|August 20, 2014
Transforming growth factor β--at the centre of systemic sclerosisRobert Lafyatis
The Open Rheumatology Journal|July 18, 2012
New insights into the mechanisms of innate immune receptor signalling in fibrosisRobert Lafyatis, Alessandra Farina
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2022
ReplyRobert Lafyatis, Tracy Tabib
Nature Reviews. Rheumatology|July 20, 2022
Assessment of disease outcome measures in systemic sclerosisRobert Lafyatis, Eleanor Valenzi
Current Opinion in Rheumatology|July 28, 2009
Innate immunity and inflammation in systemic sclerosisRobert Lafyatis, Michael York
Arthritis Research & Therapy|November 12, 2010
The cytokine language of monocytes and macrophages in systemic sclerosisRomy B Christmann, Robert Lafyatis
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Targeting fibrosis in systemic sclerosisRobert Lafyatis
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2016
Editorial: Epigenetics in Systemic SclerosisRobert Lafyatis
Nature Reviews. Rheumatology|July 4, 2012
Connective tissue disease: SSc-fibrosis takes flight with Wingless inhibitionRobert Lafyatis
Current Rheumatology Reports|November 5, 2011
Application of biomarkers to clinical trials in systemic sclerosisRobert Lafyatis
Nature Reviews. Rheumatology|August 20, 2014
Transforming growth factor β--at the centre of systemic sclerosisRobert Lafyatis
The Open Rheumatology Journal|July 18, 2012
New insights into the mechanisms of innate immune receptor signalling in fibrosisRobert Lafyatis, Alessandra Farina
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2022
ReplyRobert Lafyatis, Tracy Tabib
Nature Reviews. Rheumatology|July 20, 2022
Assessment of disease outcome measures in systemic sclerosisRobert Lafyatis, Eleanor Valenzi
Current Opinion in Rheumatology|July 28, 2009
Innate immunity and inflammation in systemic sclerosisRobert Lafyatis, Michael York
Arthritis Research & Therapy|November 12, 2010
The cytokine language of monocytes and macrophages in systemic sclerosisRomy B Christmann, Robert Lafyatis
Pageof 21